Clinical reference Biomarker Directory
Back to directory

CP

Established

Ceruloplasmin is the first-line screening test for Wilson's disease, a genetic copper-metabolism disorder.

Also known as Ceruloplasmin copper oxidase
In plain language

Ceruloplasmin carries copper in the blood, and low levels are the classic first clue for Wilson's disease, a rare condition where copper builds up to toxic levels. It's usually ordered along with a urine copper test and sometimes genetic testing to confirm the diagnosis.

Biomarker & context

Ceruloplasmin (CP) is a copper-carrying protein synthesized by the liver, best known clinically as the first-line screening test for Wilson's disease, a genetic disorder of copper metabolism causing toxic copper accumulation.

What it indicates

Low ceruloplasmin (typically <0.2 g/L or below 50% of the lower normal limit) supports a Wilson's disease diagnosis, particularly when combined with elevated 24-hour urinary copper excretion and, ideally, genetic confirmation of ATP7B mutations.

Diagnosis & clinical testing

Current guidance (EASL, AASLD, BASL) treats ceruloplasmin as a first screening step within the broader Leipzig diagnostic scoring system, not a standalone test. A significant real-world issue: one study found testing 2,847 patients to identify a single new late-onset Wilson's diagnosis over age 40, reflecting poor guideline adherence in test ordering.

Guiding treatment

False-positive low ceruloplasmin occurs in chronic liver disease and malnutrition, since ceruloplasmin synthesis itself depends on liver function — complicating diagnosis in patients who already have liver disease from another cause, which is often exactly the population being tested.

Clinical significance

Requires combination with urinary copper and genetic testing within a formal scoring system; not standalone diagnostic.

References
  1. Wilson's Disease: An Update on the Diagnostic Workup and Management. (2021). PMC.
  2. Irish Medical Journal. (2020). The Clinical Utility of a Low Serum Ceruloplasmin Measurement in the Diagnosis of Wilson Disease.